Explainer: Will COVID-19 vaccines protect us? Does efficacy equal effectiveness?
Reuters
The frontrunners in the COVID-19 vaccine race have emerged with different success rates for their shots in clinical trials, but what does that mean...
Analysis: Questions over AstraZeneca’s COVID-19 vaccine data risk delaying approval
London (Reuters) - Days after grabbing headlines with its COVID-19 “vaccine for the world”, AstraZeneca is facing tricky questions about its success rate that...
HEALTH: 6 Ways Your Mental Health Can Benefit From Exercise
by Ashley Rosa
Past studies have shown that exercise has a positive effect on a person’s mood.
A study containing 1.2 million people was conducted in...
WHO says vaccinating 20% of Latin America and Caribbean to cost more than $2 billion
Brasilia (Reuters) - Vaccinating 20% of the population of Latin America and the Caribbean against COVID-19 will cost more than $2 billion but low...
‘A special day’: End of Pfizer trial paves way for a COVID shot this year
Reuters
Pfizer Inc will seek emergency U.S. approval for its COVID-19 vaccine within days after final trial results showed its shot had a 95% success...